Recent Scripts Data On Xifaxan?

Does anybody have the most recent scripts data on Xifaxan? Is the drug rebounding with the new sales team? How is the new sales team competing against the old sales team?

 

Looks like scripts are recovering from that bad hit when we lost all those reps to Synergy. Not knocking cover off the ball though. From what Paul Herendeen is saying he thought the Magnifica team will hit stride in September / October (6 months in).

xifaxan scripts (IMS data)
16,463 (Q1 16)
16,618 (Q2 16)
16,712 (Q3 16)
17,201 (Q4 16)
16,144 (Q1 17)
16,796 (Q2 17)

 

Company just reported that Xifaxan revenue was up 16% over prior quarter! Good job everyone!

Salix is back!!

 

Doesn't matter. Revenues continues to fall.

 

what are you talking about? Salix revenue was up 16%! You must be talking about other divisions (like derm).
Our Salix people are finally hitting a stride after the Synergy debacle start of the year.

 

What caused the Synergy debacle? Was Synergy just paying a ton of money that people could not refuse or were people afraid Salix was getting sold and they would lose their job? Did management do anything to alleviate their fears?

 

Overall, son!